Author: | G. Allen Power | ISBN: | 9781938870675 |
Publisher: | Health Professions Press, Inc. | Publication: | November 18, 2016 |
Imprint: | Health Professions Press, Inc. | Language: | English |
Author: | G. Allen Power |
ISBN: | 9781938870675 |
Publisher: | Health Professions Press, Inc. |
Publication: | November 18, 2016 |
Imprint: | Health Professions Press, Inc. |
Language: | English |
Reducing the use of psychotropic drugs in the symptomatic treatment of dementia is key to successfully implementing compassionate, person-centered practices in your organization—and this book shows clearly why and how it can be done. The revised second edition of this award-winning resource introduces new research, language, and examples to reinforce the core message that antipsychotic medications are not the solution to ease the distress experienced by individuals living with dementia. Outlined here is the information and inspiration you need to provide alternative solutions for individualized support and care.
IN THIS BOOK YOU’LL FIND:
• enlightened models to reduce the use of harmful medications by understanding and addressing underlying causes of distress
• a pathway to accomplish drug-reduction goals established by the U.S. Centers for Medicare and Medicaid Services (CMS)
• discussions of new drug studies and government reports on the dangers and ineffectiveness of antipsychotic medications in the treatment of people living with dementia
• recognized best practices in dementia care and their transformational results
• case studies, stories, and other educational tools illustrating positive outcomes for people living with dementia
• ways to respond to anxiety and distress in people living with dementia
An essential read for all professionals in long-term care, including administrators, medical directors, nursing staff, psychologists and counsellors, social workers, and policy makers, the ideas presented here call for a revolution in dementia care—one that always puts the person first.
“This second edition of a classic. . . . Offers new hope for the future of aging and care.”
—Peter Whitehouse, M.D., Professor of Neurology, Case Western Reserve University
“. . . a tour de force. The first edition of the book was excellent, yet the second edition is even more enriching.”
—Karen Love, Executive Director, Dementia Action Alliance
Reducing the use of psychotropic drugs in the symptomatic treatment of dementia is key to successfully implementing compassionate, person-centered practices in your organization—and this book shows clearly why and how it can be done. The revised second edition of this award-winning resource introduces new research, language, and examples to reinforce the core message that antipsychotic medications are not the solution to ease the distress experienced by individuals living with dementia. Outlined here is the information and inspiration you need to provide alternative solutions for individualized support and care.
IN THIS BOOK YOU’LL FIND:
• enlightened models to reduce the use of harmful medications by understanding and addressing underlying causes of distress
• a pathway to accomplish drug-reduction goals established by the U.S. Centers for Medicare and Medicaid Services (CMS)
• discussions of new drug studies and government reports on the dangers and ineffectiveness of antipsychotic medications in the treatment of people living with dementia
• recognized best practices in dementia care and their transformational results
• case studies, stories, and other educational tools illustrating positive outcomes for people living with dementia
• ways to respond to anxiety and distress in people living with dementia
An essential read for all professionals in long-term care, including administrators, medical directors, nursing staff, psychologists and counsellors, social workers, and policy makers, the ideas presented here call for a revolution in dementia care—one that always puts the person first.
“This second edition of a classic. . . . Offers new hope for the future of aging and care.”
—Peter Whitehouse, M.D., Professor of Neurology, Case Western Reserve University
“. . . a tour de force. The first edition of the book was excellent, yet the second edition is even more enriching.”
—Karen Love, Executive Director, Dementia Action Alliance